p19ARF-induced p53-independent apoptosis largely occurs through BAX

Biochemical and Biophysical Research Communications

Volumn 312, Issue 4, 2003, Pages 1273-1277

  Suzuki, Hiroaki ^a,b   Kurita, Megumi ^a,b   Mizumoto, Kiyohisa ^b   Nishimoto, Ikuo ^a   Ogata, Etsuro ^c   Matsuoka, Masaaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Apoptosis; Bax; Cell cycle arrest; p53; The ARF tumor suppressor

Indexed keywords

PROTEIN BAX; PROTEIN P19; PROTEIN P21; PROTEIN P53; BAK1 PROTEIN, HUMAN; BAK1 PROTEIN, MOUSE; BAX PROTEIN, HUMAN; BAX PROTEIN, MOUSE; CDKN2A PROTEIN, MOUSE; MEMBRANE PROTEIN; ONCOPROTEIN; PROTEIN BAK; PROTEIN BCL 2; PROTEIN P14ARF; PROTEIN P16INK4A; STAUROSPORINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; UPREGULATION; VIRUS GENOME; ANIMAL; CELL CULTURE; CELL CYCLE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; KIDNEY; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT;

SV40 VIRUS;

ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; KIDNEY; MEMBRANE PROTEINS; MICE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STAUROSPORINE; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0344926304     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.071     Document Type: Article

References (27)

1. Quelle D.E., Zindy F., Ashmun R.A., Sherr C.J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:1995;993-1000.
2. Bates S., Phillips A.C., Clarke P.A., Stott F., Peters G., Ludwig R.L., Vousden K.H. p14ARF links the tumour suppressors RB and p53. Nature. 395:1998;124-125.
3. Sharpless N.E., Bardeesy N., Lee K.H., Carrasco D., Castrillon D.H., Aguirre A.J., Wu E.A., Horner J.W., DePinho R.A. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature. 413:2001;86-91.
4. Krimpenfort P., Quon K.C., Mooi W.J., Loonstra A., Berns A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature. 413:2001;83-86.
5. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 91:1997;649-659.
6. Pomerantz J., Schreiber-Agus N., Lieois N.J., Silverman A., Alland L., Chin L., Potes J., Chen K., Orlow I., Lee H.-W., Cordon-Cardo C., DePinho R. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2s inhibition of p53. Cell. 92:1998;713-723.
7. Zhang Y., Xiong Y., Yarbrough W.G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 92:1998;725-734.
8. Stott F.J., Bates S., James M.C., McConnell B.B., Starborg M., Brookes S., Palmero I., Ryan K., Hara E., Vousden K.H., Peters G. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:1998;5001-5014.
9. Eischen C.M., Weber J.D., Roussel M.F., Sherr C.J., Cleveland J.L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13:1999;2658-2669.
10. Lindstrom M.S., Klangby U., Inoue R., Pisa P., Wiman K.G., Asker C.E. Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus. Exp. Cell Res. 256:2000;400-410.
11. Moller M.B., Ino Y., Gerdes A.M., Skjodt K., Louis D.N., Pedersen N.T. Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma. Leukemia. 13:1999;453-459.
12. Sanchez-Cespedes M., Reed A.L., Buta M., Wu L., Westra W.H., Herman J.G., Yang S.C., Jen J., Sidransky D. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene. 18:1999;5843-5849.
13. Weber J.D., Jeffers J.R., Rehg J.E., Randle D.H., Lozano G., Roussel M.F., Sherr C.J., Zambetti G.P. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev. 14:2000;2358-2365.
14. Carnero A., Hudson J.D., Price C.M., Beach D. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat. Cell Biol. 2:2000;148-155.
15. Hemmati P.G., Gillissen B., von Haefen C., Wendt J., Starck L., Guner D., Dorken B., Daniel P.T. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Oncogene. 21:2002;3149-3161.
16. ARF tumor suppressor. Biochem Biophys Res Commun. 295:2002;621-629.
17. Matsuoka M., Kurita M., Sudo H., Mizumoto K., Nishimoto I., Ogata E. Multiple domains of p19ARF are involved in p53-independent apoptosis. Biochem. Biophys. Res. Commun. 301:2003;1000-1010.
18. Nakazawa Y., Kamijo T., Koike K., Noda T. ARF tumor suppressor induces mitochondria-dependent apoptosis by modulation of mitochondrial Bcl-2 family proteins. J. Biol. Chem. 278:2003;27888-27895.
19. Scorrano L., Korsmeyer S.J. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem. Biophys. Res. Commun. 304:2003;437-444.
20. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 292:2001;727-730.
21. Kanegae Y., Lee G., Sato Y., Tanaka M., Nakai M., Sakaki T., Sugano S., Saito I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23:1995;3816-3821.
22. Tsuji K., Mizumoto K., Yamochi T., Nishimoto I., Matsuoka M. Differential effect of ik3-1/cables on p53- and p73-induced cell death. J. Biol. Chem. 277:2002;2951-2957.
23. Kamijo T., Weber J.D., Zambetti G., Zindy F., Roussel M.F., Sherr C.J. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA. 95:1998;8292-8297.
24. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:2000;1053-1058.
25. Yu J., Zhang L., Hwang P.M., Kinzler K.W., Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell. 7:2001;673-682.
26. Fatyol K., Szalay A.A. The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits HIF-1-mediated transcription. J. Biol. Chem. 276:2001;28421-28429.
27. Martelli F., Hamilton T., Silver D.P., Sharpless N.E., Bardeesy N., Rokas M., DePinho R.A., Livingston D.M., Grossman S.R. p19ARF targets certain E2F species for degradation. Proc. Natl. Acad. Sci. USA. 98:2001;4455-4460.